BioSpace News Archive

Browse BioSpace’s published news and press releases by year, month, and day.
117 Results
Year
Month
Day
  • Healthline to Host Live Town Hall Featuring Dr. Anthony Fauci Save the Date: Tuesday, August 18, 2020, 11:45 a.m.-12:45 p.m. EDT SAN FRANCISCO--( BUSINESS WIRE )-- The nation’s premier epidemiologist, Dr. Anthony S. Fauci, M.D. , will headline a live town hall about the ramifications of COVID-19 on Americans’ mental health, back to school and other issues related to the pandemic. Hosted by the leading digital health brand Healthline.com , the ev
  • Emerald Bioscience, Inc. (OTCQB: EMBI) (“Emerald”), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, today announced that it has priced a registered offering of an aggregate of 116,666,668 units, each consisting of (i) one share of common stock (or common stock equivalent), and (ii) one warrant to purchase one share of common stock, at a purchase price of $0.06 per unit.
  • Happiness Biotech Group Limited (the “Company” or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today that the Company has declared a cash dividend of $0.015 per ordinary share, payable in cash on or about August 17, 2020, to shareholders of record on August 10, 2020.
  • Mesa Biotech, developers of an affordable, easy to use, handheld testing platform for infectious diseases diagnosis, today announced it has been awarded a contract up to $15.4 million from the National Institutes of Health’s (NIH) Rapid Acceleration of Diagnostics (RADx) program for its Accula™ SARS-CoV-2 Test, which gives COVID-19 diagnostic results in 30 minutes at the point of care (POC)
  • Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that the United States Patent and Trademark Office has granted Achieve a patent (US 2020/0172544 A1) on novel a
  • Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced preliminary results for the first cohort of 223 subjects from its ongoing Phase 2 long-term safety study evaluating ARQ-151 (topical roflumilast cream) 0.3%
  • FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”), today announced that it has entered into definitive agreements with investors for the purchase and sale of 2,762,430 Class B Subordinate Voting Shares of the Company (“Shares”) and warrants to purchase 1,381,215 Shares (collectively, the “Securities”) at a purchase price of US$3.62 per Share in a registered direct offering. The warrants will have an
  • Hoth to receive equity stake in Isoprene, full license of VNLG-152 and royalties from Isoprene for all other fields including Oncology
  • In response to a recent article published by the Miami Herald reporting that 17 anesthesiology residents in Florida contracted COVID-19, AARKEN, LLC, creator and producer of the Disposable Protective Barrier Enclosure, Vapor Guard ™ , announced today their intent to provide select Integrated Delivery Networks’ front-line healthcare wo
  • Oncopeptides AB announces that the number of shares and votes in Oncopeptides has changed as a result of shares being registered due to the directed share issue which was carried out in May 2020 and due to the exercise of warrants under the company’s incentive program.